Improving imaging techniques for lung cancer treatments
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
This study is looking to improve how we use special imaging techniques to see how well new lung cancer treatments are working for patients with non-small cell lung cancer, using advanced technology that can be easily accessed online.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10906117 on NIH RePORTER |
What this research studies
This research focuses on enhancing quantitative PET imaging methods to evaluate the effectiveness of immune checkpoint inhibitor therapies in patients with non-small cell lung cancer (NSCLC). By utilizing genetically-engineered mouse models, the team aims to develop and implement advanced imaging techniques that can be accessed through a web-based platform. This approach will help in better understanding patient responses to treatments and improve the overall management of lung cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with non-small cell lung cancer who are considering or currently undergoing immune checkpoint inhibitor therapy.
Not a fit: Patients with lung cancer who are not eligible for immune checkpoint inhibitor therapies or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for lung cancer patients by optimizing therapy effectiveness monitoring.
How similar studies have performed: Previous research has shown promising results in using advanced imaging techniques for cancer therapies, indicating that this approach has the potential for success.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Kinahan, Paul E. — University of Washington
- Study coordinator: Kinahan, Paul E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.